-
02:27:16 PM
Sign in with email
Forgot your password?
Register with email
Account Verification

BNTX Stock News

10/01/21 8:00 AM
Nasdaq : GMAB, BNTX
Genmab Announces Abstracts Evaluating Investigational Solid Tumor Therapies to be Presented at the Society for Immunotherapy of Cancer’s 36th Annual Meeting (SITC 2021)
Genmab A/S announced today that multiple abstracts evaluating several investigational therapies and technologies in the company’ s solid tumor product pipeline will be presented at the Society for Immunotherapy of Cancer’ s 36 th Annual Meeting, being held in Washington, DC, and virtually, November 10-14. The presentations will include a mini-oral session...
RHEA-AI
positive
10/01/21 2:00 AM
Nasdaq : BNTX
clinical trial
BioNTech Expands Clinical Oncology Portfolio with First Patient Dosed in Phase 2 Trial of mRNA-based Individualized Immunotherapy BNT122 in Colorectal Cancer Patients
Second Phase 2 trial initiated from BioNTech’s proprietary individualized mRNA-based cancer vaccine platform iNeST Randomized Phase 2 trial will enroll approximately 200 patients with high-risk colorectal cancer that are circulating tumor DNA positive after adjuvant treatment BioNTech-sponsored
RHEA-AI
neutral
09/28/21 6:45 AM
NYSE, Nasdaq : PFE, BNTX
covid-19
Pfizer and BioNTech Submit Initial Data to U.S. FDA From Pivotal Trial of COVID-19 Vaccine in Children 5 to <12 Years of Age
Pfizer Inc. and BioNTech SE announced they have submitted data to the U.S. Food and Drug Administration from the Phase 2/ 3 trial of their COVID-19 vaccine in children 5 to This press release features multimedia. A formal submission to request Emergency Use Authorization of the companies’ COVID-19 vaccine in children 5 to European...
RHEA-AI
neutral
09/22/21 9:44 PM
NYSE, Nasdaq : PFE, BNTX
covid-19
Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine Booster
Pfizer Inc. and BioNTech SE today announced that the U.S. Food and Drug Administration has authorized for emergency use a booster dose of the Pfizer-BioNTech COVID-19 Vaccine for individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age whose...
RHEA-AI
neutral
09/22/21 6:02 AM
Nasdaq : BNTX
covid-19
Pfizer and BioNTech Expand Collaboration with U.S. to Provide 500 Million Additional COVID-19 Vaccine Doses at Not-For-Profit Price for Donation to Poorest Countries
Expanded agreement brings the total number of COVID-19 vaccine doses to be supplied to the U.S. government for donation to one billion Effort contributes to companies’ pledge to deliver two billion COVID-19 vaccine doses to low- and middle-income countries by the end of 2022 NEW YORK and MAINZ,
RHEA-AI
neutral
09/20/21 6:45 AM
NYSE, Nasdaq : PFE, BNTX
covid-19
Pfizer and BioNTech Announce Positive Topline Results From Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years
Results are the first from a pivotal trial of any COVID-19 vaccine in children under 12 years of age In participants 5 to 11 years of age, the vaccine was safe, well tolerated and showed robust neutralizing antibody responses Companies plan to submit these data to the FDA, EMA and other regulatory agencies around the world as soon as possible Results in children...
RHEA-AI
neutral